20 (AIDX) Accumulated Expenses (2024 - 2026)

20's (AIDX) quarterly Accumulated Expenses came in at $598335.0 in Q1 2026, down 23.86% on a QoQ basis from $785784.0 in Q4 2025.

20 (AIDX) Accumulated Expenses (2024 - 2026) Analysis & Trends

20 (AIDX) has 3 years of Accumulated Expenses data on file, last reported at $598335.0 in Q1 2026.

Quarterly Accumulated Expenses changed N/A year-over-year to $598335.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $598335.0 (changed N/A YoY) and the FY2025 annual result came in at $785784.0, up 126.7% from the prior year.
Accumulated Expenses eased to $598335.0 in Q1 2026, from $785784.0 in the prior quarter.
In the past five years, Accumulated Expenses ranged from a high of $785784.0 in Q4 2025 to a low of $346622.0 in Q4 2024.
A 3-year average of $576913.7 and a median of $598335.0 in 2026 frame the typical range for Accumulated Expenses.
The widest YoY moves for Accumulated Expenses: up 126.7% in 2025, down 126.7% in 2025.
Tracing AIDX's Accumulated Expenses over 3 years: stood at $346622.0 in 2024, then soared by 126.7% to $785784.0 in 2025, then retreated by 23.86% to $598335.0 in 2026.
The last three Accumulated Expenses figures came in at $598335.0 (Q1 2026), $785784.0 (Q4 2025), and $346622.0 (Q4 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn
10	20	6.00 Mn	1.45 Mn	304,727.00

Download Data